Lily Cipolla

Lily Cipolla is a highly experienced Senior Medical Science Liaison with a robust background in various therapeutic areas, including autoimmune disorders, central nervous system conditions, gastrointestinal issues, and rare diseases. Currently serving at Aurinia Pharmaceuticals Inc. since May 2020, Lily specializes in autoimmune disorders such as rheumatoid arthritis and lupus nephritis. Previous roles include Field Advocacy Manager and Senior Medical Science Liaison at Sage Therapeutics, where Lily focused on women's mental health, as well as Senior Medical Science Liaison positions at Mallinckrodt Pharmaceuticals and Ironwood Pharmaceuticals, addressing rare diseases and gastrointestinal disorders, respectively. Additionally, Lily has substantial experience in immune disorders and insomnia from earlier positions at Amgen and Sepracor Inc. Lily holds a Pharm.D. and completed a residency in ambulatory care at the University of Southern California.